Study to Evaluate the Pharmacokinetics and Drug-Drug Interactions of Setanaxib in Healthy Adult Male and Female Subjects
Clinical trial NCT04327089 · COMPLETED
Trial details
- NCT number
- NCT04327089
- Sponsor
- Calliditas Therapeutics AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-24
- Primary completion
- 2021-03-23
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.